Grant: Operating Grant: Women's Health Clinical Mentorship Grant
University of Calgary
$50,000.00
Exogenous estrogen exposure and cardiovascular risk in women
FY 2019-20
Summary
Cardiovascular (CV) disease is the leading cause of death in women globally, highlighting the importance of studying sex-specific cardiovascular risk factors, such as exposure to estrogens. Sixty percent of reproductive age women use a contraceptive, and globally 60000 women become menopausal daily. The birth control pill and postmenopausal hormone therapy taken by mouth are associated with increased risk of hypertension and heart attack, though how a women takes estrogen hormones (by mouth or by another route, such as through the skin or other) of may change this risk. The goal of the proposed program of research is to investigate the association between how a women takes estrogen (by mouth or not) and cardiovascular risk in women. We hypothesize that non-oral exogenous estrogen, compared to oral exogenous estrogen, exposure will be associated with lower markers of cardiovascular risk.
We will evaluate the role of the route of administration (by mouth or other) of estrogen on the risk of high blood pressure and heart disease throughout a woman's life. How stiff a person's blood vessels are is a marker of future risk of heart attack. We will measure and compare the blood vessel stiffness in healthy postmenopausal women using non-oral (not by mouth) hormone therapy to that of menopausal women using oral hormone therapy and women not using any hormone therapy. This research program will advance our understanding of how commonly used estrogens impact cardiovascular risk and address the broader understanding of women's cardiovascular health.
Department
Program
Operating Grant: Women's Health Clinical Mentorship Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
415561
Name
Ahmed Sofia B
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Clinical
Prcname2
Women's Health Clinical Mentorship Grant
Projecttitle
Exogenous estrogen exposure and cardiovascular risk in women
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Operating Grant: Women's Health Clinical Mentorship Grant
Keyworddelim
Angiotensin Ii; Arterial Stiffness; Cardiovascular; Estrogen; Female; Hormone Therapy; Menopause; Route Of Administration; Women
Abstract
Cardiovascular (CV) disease is the leading cause of death in women globally, highlighting the importance of studying sex-specific cardiovascular risk factors, such as exposure to estrogens. Sixty percent of reproductive age women use a contraceptive, and globally 60000 women become menopausal daily. The birth control pill and postmenopausal hormone therapy taken by mouth are associated with increased risk of hypertension and heart attack, though how a women takes estrogen hormones (by mouth or by another route, such as through the skin or other) of may change this risk. The goal of the proposed program of research is to investigate the association between how a women takes estrogen (by mouth or not) and cardiovascular risk in women. We hypothesize that non-oral exogenous estrogen, compared to oral exogenous estrogen, exposure will be associated with lower markers of cardiovascular risk.
We will evaluate the role of the route of administration (by mouth or other) of estrogen on the risk of high blood pressure and heart disease throughout a woman's life. How stiff a person's blood vessels are is a marker of future risk of heart attack. We will measure and compare the blood vessel stiffness in healthy postmenopausal women using non-oral (not by mouth) hormone therapy to that of menopausal women using oral hormone therapy and women not using any hormone therapy. This research program will advance our understanding of how commonly used estrogens impact cardiovascular risk and address the broader understanding of women's cardiovascular health.
Competitiondate
201910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ahmed, Sofia B
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~